Antioxidant support to ameliorate the oxaliplatin-dependent microglial alteration: Morphological and molecular study

Oxaliplatin is a third-generation chemotherapy drug mainly used for colorectal cancer treatment. However, it is also known to trigger neuropathy whose underlying neurobiological mechanisms are still under investigation and currently available treatments show limited efficacy. It is now established t...

Descripción completa

Detalles Bibliográficos
Autores principales: Branca, Jacopo J.V., Carrino, Donatello, Paternostro, Ferdinando, Gulisano, Massimo, Becatti, Matteo, Di Cesare Mannelli, Lorenzo, Pacini, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607276/
https://www.ncbi.nlm.nih.gov/pubmed/34755507
http://dx.doi.org/10.4081/ejh.2021.3285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607276/
https://www.ncbi.nlm.nih.gov/pubmed/34755507
http://dx.doi.org/10.4081/ejh.2021.3285

Ejemplares similares